Chronic Urticaria in Special Populations: Pediatric, Pregnancy, and the Elderly

Matthew Robson1, Joshua S Bernstein1, Jonathan A Bernstein1

  • 1Division of Rheumatology, Allergy, and Immunology, Department of Internal Medicine, University of Cincinnati College of Medicine, 231 Albert Sabin Way ML#563, Cincinnati, OH 45267, USA.

Insights

Chronic spontaneous urticaria (CSU) treatment guidelines are lacking for vulnerable groups. This review updates CSU management in children, pregnant women, and the elderly, addressing prevalence, diagnosis, and treatment options.

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Chronic urticaria is an inflammatory skin condition causing hives and swelling.
  • Current treatment guidelines for chronic spontaneous urticaria (CSU) have gaps concerning specific populations.
  • Vulnerable groups like children, pregnant women, and the elderly require tailored CSU management strategies.

Purpose of the Study:

  • To provide an updated review of chronic spontaneous urticaria (CSU) management.
  • To focus on special populations: children (0-18 years), pregnant women, and the elderly (>65 years).
  • To define prevalence, diagnostic considerations, and explore current/future management options for CSU in these groups.

Main Methods:

  • Literature review of existing studies and treatment guidelines.
  • Analysis of prevalence data for CSU in pediatric, pregnant, and geriatric cohorts.
  • Exploration of diagnostic challenges and therapeutic strategies specific to each population.

Main Results:

  • Prevalence and diagnostic nuances of CSU vary across pediatric, pregnant, and elderly populations.
  • Current evidence suggests specific adaptations for antihistamine and other therapies in these groups.
  • Future research directions are identified for optimizing CSU care in vulnerable individuals.

Conclusions:

  • CSU management requires population-specific approaches for children, pregnant women, and the elderly.
  • Addressing treatment gaps in these vulnerable groups is crucial for improving patient outcomes.
  • Further research is needed to establish definitive, evidence-based guidelines for CSU in special populations.

Related Concept Videos

Hypersensitivities01:30

Hypersensitivities

Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
580
Allergic Reactions02:06

Allergic Reactions

Overview
27.3K
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
244
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
271